Singapore-US Strategic Dialogue on Biosecurity

: Singapore is poised to be a critical partner to the US in minimizing biosecurity challenges in Southeast Asia. As a nation, it is vulnerable to both emerging infectious disease and potential terrorism in the region. In addition to its geographical importance within the Asia-Pacific region, Singapore is a rising powerhouse in biotechnology, having invested $13.2B in biotech R&D from 2011-2015. As a result, it has become an attractive site for international biotechnology companies like Novartis, as well as world-class research universities. It is home to government and academic expertise capable of identifying and responding to biosecurity challenges. Its expertise is, in many ways, complementary to that of the US in these realms.